EICHORCondition: Kidney Disease · Sponsor: GlaxoSmithKline
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is being given. Part A is testing the new study treatment on healthy people. This is to see if it's safe, what it does to the body, and how the body's defense system responds to it. Part B is similar, but the study treatment will be given to people who have a kidney disease called autosomal dominant polycystic kidney disease (ADPKD).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| GSK Investigational Site | Rochester, Minnesota, United States | — |
| GSK Investigational Site | Brussels, Belgium | — |
| GSK Investigational Site | Ghent, Belgium | — |
| GSK Investigational Site | Leuven, Belgium | — |
| GSK Investigational Site | London, Ontario, Canada | — |
| GSK Investigational Site | Toronto, Ontario, Canada | — |
| GSK Investigational Site | Montreal, Quebec, Canada | — |
| GSK Investigational Site | Brest, France | — |
| GSK Investigational Site | Paris, France | — |
| GSK Investigational Site | Cologne, North Rhine-Westphalia, Germany | — |
| GSK Investigational Site | Lübeck, Schleswig-Holstein, Germany | — |
| GSK Investigational Site | Groningen, Netherlands | — |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06734234